Literature DB >> 21385551

Rituximab is effective in the treatment of patients with idiopathic inflammatory myopathy.

F J Garcia-Hernandez, R Gonzalez-Leon, M J Castillo-Palma, J Sanchez-Roman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21385551

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN： 0392-856X            Impact factor:   4.473


× No keyword cloud information.
  2 in total

Review 1.  Targeted immunotherapy trials for idiopathic inflammatory myopathies.

Authors:  Joerg-Patrick Stübgen
Journal:  J Neurol       Date:  2012-06-30       Impact factor: 4.849

Review 2.  Abatacept as a successful therapy for myositis—a case-based review.

Authors:  Anne M Kerola; Markku J Kauppi
Journal:  Clin Rheumatol       Date:  2014-02-04       Impact factor: 2.980
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.